Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Celecoxib after total knee arthroplasty
ChiCTR-ONRC-13003785Phase 4Completed
- Sponsor
- First Affiliated Hospital of Guangzhou University of Chinese Medicine
- Start
- Nov 2013
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of celecoxib in knee osteoarthritis (OA) (2 arms), sponsored by First Affiliated Hospital of Guangzhou University of Chinese Medicine. Primary endpoints: Knee temperature, White blood cell count and 3 more. Started Nov 2013; status: completed.
02
Drugs
celecoxib
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on ChiCTR-ONRC-13003785.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-ONRC-13003785.